Acute, unilateral breast toxicity from gemcitabine in the setting of thoracic inlet obstruction

Kipp Weiskopf; David Creighton; Thomas Lew; Jennifer L. Caswell; David Ouyang; Arpeet T. Shah; Lawrence V. Hofmann; Joel W. Neal; Melinda L. Telli

doi:10.1200/JOP.2016.014241

Acute, unilateral breast toxicity from gemcitabine in the setting of thoracic inlet obstruction

Kipp Weiskopf, David Creighton, Thomas Lew, Jennifer L. Caswell, David Ouyang, Arpeet T. Shah, Lawrence V. Hofmann, Joel W. Neal, Melinda L. Telli

School of Medicine

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	763-764
Number of pages	2
Journal	Journal of oncology practice
Volume	12
Issue number	8
DOIs	https://doi.org/10.1200/JOP.2016.014241
State	Published - Aug 2016

ASJC Scopus subject areas

Oncology
Oncology(nursing)
Health Policy

Access to Document

10.1200/JOP.2016.014241

Cite this

@article{ac2366c556004ea0b20aa4b5257b56cf,

title = "Acute, unilateral breast toxicity from gemcitabine in the setting of thoracic inlet obstruction",

author = "Kipp Weiskopf and David Creighton and Thomas Lew and Caswell, {Jennifer L.} and David Ouyang and Shah, {Arpeet T.} and Hofmann, {Lawrence V.} and Neal, {Joel W.} and Telli, {Melinda L.}",

note = "Funding Information: Supported by National Institutes of Health Training Grant No. T32GM007365 (K.W.). Genentech, Merck, ArQule, Novartis, Exelixis, Boehringer Ingelheim, Nektar",

year = "2016",

month = aug,

doi = "10.1200/JOP.2016.014241",

language = "English (US)",

volume = "12",

pages = "763--764",

journal = "Journal of oncology practice",

issn = "1554-7477",

publisher = "American Society of Clinical Oncology",

number = "8",

}

TY - JOUR

T1 - Acute, unilateral breast toxicity from gemcitabine in the setting of thoracic inlet obstruction

AU - Weiskopf, Kipp

AU - Creighton, David

AU - Lew, Thomas

AU - Caswell, Jennifer L.

AU - Ouyang, David

AU - Shah, Arpeet T.

AU - Hofmann, Lawrence V.

AU - Neal, Joel W.

AU - Telli, Melinda L.

N1 - Funding Information: Supported by National Institutes of Health Training Grant No. T32GM007365 (K.W.). Genentech, Merck, ArQule, Novartis, Exelixis, Boehringer Ingelheim, Nektar

PY - 2016/8

Y1 - 2016/8

UR - http://www.scopus.com/inward/record.url?scp=84981742231&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84981742231&partnerID=8YFLogxK

U2 - 10.1200/JOP.2016.014241

DO - 10.1200/JOP.2016.014241

M3 - Article

C2 - 27511721

AN - SCOPUS:84981742231

SN - 1554-7477

VL - 12

SP - 763

EP - 764

JO - Journal of oncology practice

JF - Journal of oncology practice

IS - 8

ER -

Acute, unilateral breast toxicity from gemcitabine in the setting of thoracic inlet obstruction

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this